What is the sipra membership?

Could you be a candidate for a GLP-1 medication?

Jillian Foglesong Stabile, MD

FAAFP, DABOM · Reviewed June 10, 2026 · BMI-based self-screen

Question 1 of 4

Which range is your body mass index (BMI) in? BMI is your weight in kilograms divided by your height in meters squared.

Educational self-screen only. Not an approval, diagnosis, or guarantee of treatment. A licensed physician determines eligibility and makes the final decision. Individual results vary.

Chapter 01 · The criteria

Who the criteria are written for

GLP-1 medications approved for chronic weight management are indicated, alongside a reduced-calorie diet and increased physical activity, for adults with a body mass index of 30 or higher, or 27 or higher when a weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol is also present.¹ This self-screen reflects those BMI-based criteria; it is not an approval and not a diagnosis.

BMI is a rough screening number, not the whole picture. It does not account for muscle, body composition, or where weight is carried, so a clinician interprets it alongside your waist measurement, your history, and your goals rather than treating the number alone.

Chapter 02 · How it works

What a GLP-1 medication is, and who decides

GLP-1 (glucagon-like peptide-1) is a hormone the body makes that helps regulate appetite and blood sugar; these medications are synthetic versions used as one part of a plan that includes nutrition and activity. To be clear about who does what: sipra connects you with US-licensed physicians who decide whether a medication is appropriate for you. We are not the compounder, and compounded medications are not FDA-approved and are not equivalent to the brand-name products. A licensed physician makes the final decision after reviewing your history. Individual results vary.

Some people should not take these medications, or need extra caution, including those with a personal or family history of medullary thyroid cancer or MEN2, those who are pregnant or planning pregnancy, and those with certain other conditions. This is why the screen routes anyone with those flags to a clinician first, regardless of BMI.

Chapter 03 · The fine print

What this self-screen does not do

This tool does not approve you for any medication, diagnose any condition, or guarantee that a physician will prescribe treatment. It mirrors the published BMI-based criteria so you can see roughly where you stand before a visit. Eligibility, safety, and the choice of any treatment are clinical decisions a licensed physician makes after reviewing your full history. Individual results vary.

Meeting the criteria is not the same as being approved. A licensed physician reviews your history, weighs risks and benefits, and makes the final decision.

Every medication on sipra is prescribed by a licensed physician, so your care always starts with a visit. Your sipra membership gives you ongoing access to those physician visits, so you can check in, adjust your plan, and ask questions whenever you need, without paying per visit. It is how we keep high-quality care convenient: one membership, physician access whenever you need it, and support at every step.

Sources

US Food and Drug Administration. "FDA Approves New Drug Treatment for Chronic Weight Management." FDA News Release, 2021 (BMI >= 30, or >= 27 with at least one weight-related condition). fda.gov
Garvey WT, Mechanick JI, Brett EM, et al. "American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity." Endocr Pract. 2016;22(Suppl 3):1-203. doi.org

Compounded medications are not FDA-approved and require a patient-specific prescription. Brand names are trademarks of their owners; sipra is not affiliated with them.

General education, not medical advice. Last reviewed June 10, 2026 by Jillian Foglesong Stabile, MD, FAAFP, DABOM. Prices snapshot BMI-based self-screen. Individual results vary.